Meria P - Search Results

1

18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer.

Quero L, Vercellino L, de Kerviler E, Mongiat-Artus P, Culine S, Merlet P, Ravery V, Meria P, Desgrandchamps F, Hennequin C. Quero L, et al. Among authors: meria p. Clin Nucl Med. 2015 Nov;40(11):e492-5. doi: 10.1097/RLU.0000000000000932. Clin Nucl Med. 2015. PMID: 26252326

2

2022 Recommendations of the AFU Lithiasis Committee: Management of symptomatic urinary stones.

Meria P, Raynal G, Denis E, Plassais C, Cornet P, Gil-Jardiné C, Almeras C; Lithiasis Committee of the French Association of Urology (CLAFU). Meria P, et al. Prog Urol. 2023 Nov;33(14):791-811. doi: 10.1016/j.purol.2023.08.018. Prog Urol. 2023. PMID: 37918980 Review.

3

2022 Recommendations of the AFU Lithiasis Committee: Medical management - from diagnosis to treatment.

Lemoine S, Dahan P, Haymann JP, Meria P, Almeras C; Lithiasis Committee of the French Association of Urology (CLAFU). Lemoine S, et al. Among authors: meria p. Prog Urol. 2023 Nov;33(14):911-953. doi: 10.1016/j.purol.2023.08.004. Prog Urol. 2023. PMID: 37918992 Review.

4

Subcutaneous urinary diversions for palliative treatment of pelvic malignancies.

Desgrandchamps F, Cussenot O, Meria P, Cortesse A, Teillac P, Le Duc A. Desgrandchamps F, et al. Among authors: meria p. J Urol. 1995 Aug;154(2 Pt 1):367-70. doi: 10.1097/00005392-199508000-00008. J Urol. 1995. PMID: 7541851 Clinical Trial.

5

[Carcinoma of Bellini's tubules].

Rousseau T, Lesourd A, Meria P, Desgrandchamps F, Cussenot O, Cortesse A, Teillac P, Le Duc A. Rousseau T, et al. Among authors: meria p. Prog Urol. 1995 Jun;5(3):402-5; discussion 405-6. Prog Urol. 1995. PMID: 7545498 French.

6

Tumour-associated trypsin inhibitor and renal cell carcinoma.

Meria P, Toubert ME, Cussenot O, Bassi S, Janssen T, Desgrandchamps F, Cortesse A, Schlageter MH, Teillac P, Le Duc A. Meria P, et al. Eur Urol. 1995;27(3):223-6. doi: 10.1159/000475165. Eur Urol. 1995. PMID: 7601186

7

Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.

Cussenot O, Villette JM, Valeri A, Cariou G, Desgrandchamps F, Cortesse A, Meria P, Teillac P, Fiet J, Le Duc A. Cussenot O, et al. Among authors: meria p. J Urol. 1996 Apr;155(4):1340-3. J Urol. 1996. PMID: 8632569

8

Laser induced autofluorescence diagnosis of bladder tumors: dependence on the excitation wavelength.

Anidjar M, Ettori D, Cussenot O, Meria P, Desgrandchamps F, Cortesse A, Teillac P, Le Duc A, Avrillier S. Anidjar M, et al. Among authors: meria p. J Urol. 1996 Nov;156(5):1590-6. J Urol. 1996. PMID: 8863545

9

Percentage of free serum prostate-specific antigen: a new tool in the early diagnosis of prostatic cancer.

Toubert ME, Guillet J, Chiron M, Meria P, Role C, Schlageter MH, Francois H, Borschneck C, Nivelon F, Desgrandchamps F, Rastel D, Cussenot O, Teillac P, Le Duc A, Najean Y. Toubert ME, et al. Among authors: meria p. Eur J Cancer. 1996 Nov;32A(12):2088-93. doi: 10.1016/s0959-8049(96)00245-6. Eur J Cancer. 1996. PMID: 9014750

10

New experimental model of ureteropelvic junction obstruction allowing easy access for percutaneous surgery.

Anidjar M, Meria P, Desgrandchamps F, Ledroux M, Cussenot O, Planet M, Teillac P, Le Duc A. Anidjar M, et al. Among authors: meria p. J Endourol. 1997 Apr;11(2):139-44. doi: 10.1089/end.1997.11.139. J Endourol. 1997. PMID: 9107589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters